Treatment-free remission in patients with chronic myeloid leukemia: recommendations of the LALNET expert panel.

Blood Adv · 2021 · PMC9153024 · PMID 34438444

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

15 Although some trials have showed a trend for better chances of maintaining TFR with longer TKI treatment, none of them has demonstrated to be statistically significant. 11,14,24 In the LALNET recommendations survey, the question regarding minimal time on treatment with TKI to consider discontinuation was answered as follows: 2 years (8%), 3 years, (34%), 4 years (25%), and 5 years (33%).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.